Summary

Global Pap Test Market is expected to grow at a significant rate of around 11.4% during the forecast period. Pap test is a process in which cells from the surface of the cervix and the vicinity are gently removed with a little brush so that they can be examined under a microscope for cervical cancer or cell alterations that may result in cervical cancer. Other disorders, including as infections or inflammation, can also be discovered with a pap test. It is typically performed concurrently with a pelvic examination and may also be concurrent with a test for specific forms of human papillomavirus (HPV), also known as the Papanicolaou test and Pap smear. The market for pap test is expected to grow significantly owing to the increasing number of HPV cases and rising awareness regarding cervical cancers. For instance, diagnosed in more than 90% of cervical cancers, the fourth deadliest cancer in women, HPV is currently the most common pathogen responsible for female cancers, as per the study conducted on the estimated lifetime probability of acquiring human papillomavirus in the United States.

Abbott, F. Hoffmann-La Roche Ltd., BD, QIAGEN, Thermo Fisher Scientific Inc., HOLOGIC, INC., Seegene Inc., Arbor Vita Corporation, Femasys Inc., Hospital Equipment Mfg. Co. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report
“Amongst method, liquid-based segment held a dominant share during the forecast period”
Based on the method, the market is segmented into liquid-based and conventional-based. The liquid-based segment held a dominant share of the market in 2021. The major reason for the growth in this segment is attributed to the advantages that are offered by these methods. Liquid-based methods have been developed to improve the diagnostic reliability of Papanicolaou (Pap) smears. Traditional methods such as conventional pap smears used to have false-negative and false-positive results owing to inefficient sampling and slide preparation, and errors in laboratory detection and interpretation. Liquid-based methods rinse cervical cells in preservatives so that blood and other potentially obscuring material can be easily separated. It also allows for additional testing of the sample, such as HPV, leading to the growth of the pap test market.

“Amongst application, the vaginal cancer screening category is expected to grow with high CAGR in 2021”
Basis of application, the market is segmented into cervical cancer screening, vaginal cancer screening, and others. In 2021, the vaginal cancer screening category is expected to grow with high CAGR attributed to rising cases and high mortality rates of vaginal cancer that have propelled the demand for effective screening tests. For instance, as per a 2018 report by the American Cancer Society, an estimated 1 out of every 1,100 women is likely to develop vaginal cancer. In 2018, 5,350 women were diagnosed with vaginal cancer in the U.S. and the number of vaginal cancer-related deaths in the U.S. was 1,430 in the same year.

“Amongst end user, home setting segment to witness significant CAGR during the forecast period”
Based on end user, the market is segmented into research laboratories, diagnostic centers, hospitals & clinics, and others. The diagnostic centers segment is expected to witness significant CAGR during the forecast period due to the rising women population suffering with cervical cancer and surge in demand for diagnosis and detection of the disease.

“North America to hold a significant share in the market”
In 2021, North America held a significant share of the global pap test market mainly due to a surge in the cases of cervical cancers, leading to the need for rising technological advancement related to the early screening for cancers during the forecast period. Technological development such as culmination of AI and big data have been used to improve the accuracy and efficiency of cervical cancer screening and automation may help overcome the labor-intensive and subjective interpretation of cellular morphology. Products from key players such as SurePath, ThinPrep, and FocalPoint GS Imaging are now commonly being used in clinical practice. Thus, these factors are driving the regional market in the forecast period.

Reasons to buy this report:
• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
• The report presents a quick review of overall industry performance at one glance.
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
• The study comprehensively covers the market across different segments.
• Deep dive regional level analysis of the industry.

Customization Options:
The global pap test market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

ページTOPに戻る

Table of Contents